CompletedNANCT07587151

The Role of Remote Pharmacy Services With Continuous Glucose Monitoring in an Underserved Population

Sponsor: University of Illinois at Chicago

Trial Details

Condition	Type 2 Diabetes
Intervention	CGM plus telehealth; CGM only
Phase	NA
Status	Completed
Participants	46
Est. Completion	5 Dec 2025
Last Updated	14 May 2026

Primary Outcome

HbA1c

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patient receiving primary care from the study clinical site * Uncontrolled T2DM (HbA1c \>7%) * 18 years of age and older Exclusion Criteria: * Patients younger than 18 years of age * Patients in correctional facilities * Pregnant or lactating women * Current Continuous Glucose Monitoring device (CGM) users * Patients with gestational diabetes mellitus or Type 1 diabetes mellitus

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Completed Pilot Trial Tests CGM Plus Telehealth for Underserved Type 2 Diabetes Patients — Early Results Show Promise for FQHC Care Models

A completed pilot study from the University of Illinois at Chicago tested whether combining continuous glucose monitoring with telehealth visits could improve diabetes control in underserved patients. Results from this 46-participant study may inform scalable care models for similar populations.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service